(All fields required)
Please enter a valid email.
Please enter your name.
What is : (So we know you are human.)
Please supply the correct answer.
The Schubert-Martin Inflammatory Bowel Disease / IBD Center at Cincinnati Children's provides a focused, team approach to comprehensive, individualized diagnosis and treatment for patients with Crohn's disease and ulcerative colitis.
We combine a multidisciplinary approach with the latest diagnostic methods, research-based treatments and surgical approaches to develop effective, customized approaches for each patient. Our center focuses on all aspects of caring for those with Inflammatory Bowel Disease / IBD, including:
We are dedicated to optimizing care for young children and teens who struggle with inflammatory bowel disease daily. They face unique challenges, such as growth, hormonal and bone health issues. Because of this, pediatric patients often need more aggressive treatments than adults. Thanks to our specialization in pediatric medicine, our team is the best resource to turn to when faced with these unique issues.
Close interaction among center members – all based at the Cincinnati Children’s Burnet Campus – means better, faster treatment for patients and their families. Our interdisciplinary approach to inflammatory bowel disease means that we treat more than just the condition; we focus on all aspects of caring, including the overall quality-of-life issues facing our patients every day.
To best manage your child’s care, please call 513-636-4415 or email firstname.lastname@example.org to schedule an appointment with us ahead of time.
Immunogenetic Determinants of Linear Growth in Pediatric IBD
This multicenter project will characterize immune and genetics determinants of linear growth in a prospective cohort of pediatric IBD patients. Read more.
Biomarkers of IBD Behavior and Treatment Response
This multicenter project will use state-of-the-art flow cytometry and genomic approaches to improve IBD patient classification with respect to disease behavior and response to therapy. Read more.
Risk stratification and identification of immunogenetic and microbial markers of rapid disease progression in children with Crohn’s disease
This multicenter project will define genetic, genomic, microbial, and immune markers of disease progression in newly diagnosed pediatric CD. There are currently 26 sites, but the number is expected to increase to 50 throughout the year. Read more.
Behavioral Treatment of Nonadherence in Pediatric Inflammatory Bowel Disease (IBD)
This randomized controlled trial will determine whether short-term behavioral therapy will improve treatment adherence in pediatric IBD.
The Use of Certolizumab Pegol for Treatment of Active Crohn's Disease in Children and Adolescents (NURTURE)
This randomized multicenter clinical trial will determine the safety and effectiveness of Cimzia (pegylated monoclonal anti-TNF-alpha antibody) in pediatric Crohn’s disease. Read more.
As part of the Division of Gastroenterology, Hepatology and Nutrition, we’re committed to providing our field with the next generation of industry-leading clinicians and researchers. Learn more about our training programs and fellowships.
As part of our mission to improve the lives of children with inflammatory bowel disease, members of the Division of Gastroenterology, Hepatology and Nutrition actively pursue research, including various aspects of IBD causes and treatment. Learn more about our current studies and projects.
Your gift to the IBD Center will support the Division of Gastroenterology, Hepatology and Nutrition. It will be processed in a completely secure environment.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY: 1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2015 Cincinnati Children's Hospital Medical Center